IBDEI11C ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17569,0)
 ;;=Z79.82^^73^849^25
 ;;^UTILITY(U,$J,358.3,17569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17569,1,3,0)
 ;;=3^Long term (current) use of aspirin
 ;;^UTILITY(U,$J,358.3,17569,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,17569,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,17570,0)
 ;;=Z79.899^^73^849^21
 ;;^UTILITY(U,$J,358.3,17570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17570,1,3,0)
 ;;=3^Long term (current) drug therapy, oth
 ;;^UTILITY(U,$J,358.3,17570,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,17570,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,17571,0)
 ;;=Z79.51^^73^849^26
 ;;^UTILITY(U,$J,358.3,17571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17571,1,3,0)
 ;;=3^Long term (current) use of inhaled steroids
 ;;^UTILITY(U,$J,358.3,17571,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,17571,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,17572,0)
 ;;=Z79.4^^73^849^27
 ;;^UTILITY(U,$J,358.3,17572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17572,1,3,0)
 ;;=3^Long term (current) use of insulin
 ;;^UTILITY(U,$J,358.3,17572,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,17572,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,17573,0)
 ;;=Z79.1^^73^849^28
 ;;^UTILITY(U,$J,358.3,17573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17573,1,3,0)
 ;;=3^Long term (current) use of non-stroidl non-inflam (NSAID)
 ;;^UTILITY(U,$J,358.3,17573,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,17573,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,17574,0)
 ;;=Z79.891^^73^849^29
 ;;^UTILITY(U,$J,358.3,17574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17574,1,3,0)
 ;;=3^Long term (current) use of opiate analgesic
 ;;^UTILITY(U,$J,358.3,17574,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,17574,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,17575,0)
 ;;=Z79.52^^73^849^30
 ;;^UTILITY(U,$J,358.3,17575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17575,1,3,0)
 ;;=3^Long term (current) use of systemic steroids
 ;;^UTILITY(U,$J,358.3,17575,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,17575,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,17576,0)
 ;;=Z91.19^^73^849^40
 ;;^UTILITY(U,$J,358.3,17576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17576,1,3,0)
 ;;=3^Pt's noncmplnc w oth med'l trmnt & regimen
 ;;^UTILITY(U,$J,358.3,17576,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,17576,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,17577,0)
 ;;=Z73.89^^73^849^32
 ;;^UTILITY(U,$J,358.3,17577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17577,1,3,0)
 ;;=3^Prblms related to life mngmt difficulty, oth
 ;;^UTILITY(U,$J,358.3,17577,1,4,0)
 ;;=4^Z73.89
 ;;^UTILITY(U,$J,358.3,17577,2)
 ;;=^5063280
 ;;^UTILITY(U,$J,358.3,17578,0)
 ;;=Z55.9^^73^849^31
 ;;^UTILITY(U,$J,358.3,17578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17578,1,3,0)
 ;;=3^Prblms related to educ & literacy, unspec
 ;;^UTILITY(U,$J,358.3,17578,1,4,0)
 ;;=4^Z55.9
 ;;^UTILITY(U,$J,358.3,17578,2)
 ;;=^5063106
 ;;^UTILITY(U,$J,358.3,17579,0)
 ;;=Z63.8^^73^849^33
 ;;^UTILITY(U,$J,358.3,17579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17579,1,3,0)
 ;;=3^Prblms related to prim support grp, oth, unspec
 ;;^UTILITY(U,$J,358.3,17579,1,4,0)
 ;;=4^Z63.8
 ;;^UTILITY(U,$J,358.3,17579,2)
 ;;=^5063174
 ;;^UTILITY(U,$J,358.3,17580,0)
 ;;=Z63.9^^73^849^34
 ;;^UTILITY(U,$J,358.3,17580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17580,1,3,0)
 ;;=3^Prblms related to prim support grp, unspec
 ;;^UTILITY(U,$J,358.3,17580,1,4,0)
 ;;=4^Z63.9
 ;;^UTILITY(U,$J,358.3,17580,2)
 ;;=^5063175
 ;;^UTILITY(U,$J,358.3,17581,0)
 ;;=Z65.8^^73^849^35
 ;;^UTILITY(U,$J,358.3,17581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17581,1,3,0)
 ;;=3^Prblms related to psychosocial circumst, oth
